Aegera Therapeutics

About:

Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.

Website: http://www.aegera.com/

Top Investors: Business Development Bank of Canada, Desjardins Venture Capital, GrowthWorks Capital, VenGrowth Asset Management, Multiple Capital

Description:

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.